Tirzepatides mean 52-pound loss at its highest dose dwarfs this class
Yes, gastrointestinal side effects including gas, bloating, and flatulence can occur with GLP-1 receptor agonist therapy
Patients should reach out if they experience persistent nausea, vomiting, or diarrhea that prevents adequate nutrition or hydration (which may lead to dehydration and kidney problems)
Theres still a bit of uncertainty around how GLP-1 medications affect the gut microbiome
Side Effects: Both drugs share similar side effects, including nausea, vomiting, and gastrointestinal discomfort, but these are generally mild and decrease over time as the body adjusts to the medication
Retatrutide is a triple agonist that targets GLP-1, GIP, and glucagon receptors